Opinion | April 17, 2026
Beyond beds and buildings: The quiet capital shift reshaping healthcare
The investment case for health technology in India is frequently overstated in one direction and understated in another
The investment case for health technology in India is frequently overstated in one direction and understated in another
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Move amid evidence of widespread reporting gaps
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Subscribe To Our Newsletter & Stay Updated
